Health Disparities and the Global Landscape of Lymphoma Care Today.

Related Articles

Health Disparities and the Global Landscape of Lymphoma Care Today.

Am Soc Clin Oncol Educ Book. 2017;37:526-534

Authors: Phillips AA, Smith DA

Abstract
Lymphoma encompass a wide variety of distinct disease entities, including, but not limited to, subtypes of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). In the last 3 decades, therapeutic advancements have resulted in substantial improvements in lymphoma outcome. In most high-income regions, HL is a largely curable disease and for patients with two frequent subtypes of NHL, diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL), survival has dramatically improved with the incorporation of rituximab as a standard treatment approach. Despite these advances, outcomes vary between and across populations. This review will provide updated information about health disparities in lymphoma in the United States and across the globe.

PMID: 28561692 [PubMed - indexed for MEDLINE]

http://ift.tt/2renTc6